Krebs Biochemicals & Industries Limited reported earnings results for the first quarter ended June 30, 2023. For the first quarter, the company reported sales was INR 105.81 million compared to INR 106.41 million a year ago. Revenue was INR 106.19 million compared to INR 107.7 million a year ago.

Net loss was INR 53.33 million compared to INR 81.37 million a year ago. Basic loss per share from continuing operations was INR 2.47 compared to INR 3.77 a year ago. Diluted loss per share from continuing operations was INR 2.47 compared to INR 3.77 a year ago.